WP
GSK icon

WMS Partners’s GSK GSK Stock Holding History

WMS Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,225
Closed -$214K – 235
2017
Q3 		$214K Hold
4,225
– – 0.03% 198
2017
Q2 		$228K Buy
+4,225
New +$225K 0.03% 193
2014
Q2 		– Sell
-4,038
Closed -$269K – 245
2014
Q1 		$269K Buy
4,038
+85
+2% +$5.75K 0.04% 201
2013
Q4 		$264K Hold
3,953
– – 0.04% 189
2013
Q3 		$248K Hold
3,953
– – 0.05% 164
2013
Q2 		$247K Buy
+3,953
New +$251K 0.05% 191

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WMS Partners's GSK Position: Q4 2017 in Review

WMS Partners sold out of GSK (GSK) in Q4 2017, closing a stake of 4,225 shares — an estimated $214K sold.

WMS Partners first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $269K in Q1 2014. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • WMS Partners reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • WMS Partners sold 4,225 GSK shares in Q4 2017, an estimated $214K.
  • WMS Partners first reported a position in GSK in Q2 2013 and held it in 6 quarters.
  • WMS Partners's GSK position peaked at $269K in Q1 2014.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on WMS Partners's 13F filing for Q4 2017, filed 9 Feb 2018.